Exide down on insurance diversification; Citi downgrades
Reuters Market Eye - Shares in Exide Industries (EXID.NS) fall 1.3 percent after Dutch banking and insurance group ING (ING.AS) said it was selling its 26 percent stake in an Indian insurance venture to local partner Exide.
Besides buying ING's 26 percent in ING Vysya, Exide said it would buy 24 percent from two other private Indian investors - Enam Group and Hemendra Kothari Group - for a total of about 5.5 billion rupees.
Citigroup downgrades Exide to "sell" from "buy" and cuts its target price to 118 rupees from 149 rupees on the news.
The bank says the acquisition of the insurance stake is "completely unrelated" to its core business and is also "loss-making", thus requiring additional incremental funding.
Citigroup adds Exide "is unlikely to find a purchaser" for the stake in the insurance unit.
(Reporting by Abhishek Vishnoi)
- Tweet this
- Share this
- Digg this
- India's Mars mission a step closer to success with engine test
- Apple sells more than 10 million new iPhones in first three days |
- PM Modi to get rock star reception in New York
- India withdraws pharma pricing regulator's power to cap non-essential drug prices
- Modi to observe strict fast during maiden trip to U.S.
India has withdrawn the drug pricing authority's powers that allowed it to fix the prices of medicines not deemed essential, after its decision to impose price caps on more than 100 drugs in July triggered industry protests. Article
India has no plans to increase food handouts - Food Minister Ram Vilas Paswan. Full Article